This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!
Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

NIH NLM Logo
Log in
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Oct 22;63(11):e00483-19.
doi: 10.1128/AAC.00483-19. Print 2019 Nov.

Validating the AMRFinder Tool and Resistance Gene Database by Using Antimicrobial Resistance Genotype-Phenotype Correlations in a Collection of Isolates

Affiliations

Validating the AMRFinder Tool and Resistance Gene Database by Using Antimicrobial Resistance Genotype-Phenotype Correlations in a Collection of Isolates

Michael Feldgarden et al. Antimicrob Agents Chemother. .

Erratum in

Abstract

Antimicrobial resistance (AMR) is a major public health problem that requires publicly available tools for rapid analysis. To identify AMR genes in whole-genome sequences, the National Center for Biotechnology Information (NCBI) has produced AMRFinder, a tool that identifies AMR genes using a high-quality curated AMR gene reference database. The Bacterial Antimicrobial Resistance Reference Gene Database consists of up-to-date gene nomenclature, a set of hidden Markov models (HMMs), and a curated protein family hierarchy. Currently, it contains 4,579 antimicrobial resistance proteins and more than 560 HMMs. Here, we describe AMRFinder and its associated database. To assess the predictive ability of AMRFinder, we measured the consistency between predicted AMR genotypes from AMRFinder and resistance phenotypes of 6,242 isolates from the National Antimicrobial Resistance Monitoring System (NARMS). This included 5,425 Salmonella enterica, 770 Campylobacter spp., and 47 Escherichia coli isolates phenotypically tested against various antimicrobial agents. Of 87,679 susceptibility tests performed, 98.4% were consistent with predictions. To assess the accuracy of AMRFinder, we compared its gene symbol output with that of a 2017 version of ResFinder, another publicly available resistance gene detection system. Most gene calls were identical, but there were 1,229 gene symbol differences (8.8%) between them, with differences due to both algorithmic differences and database composition. AMRFinder missed 16 loci that ResFinder found, while ResFinder missed 216 loci that AMRFinder identified. Based on these results, AMRFinder appears to be a highly accurate AMR gene detection system.

Keywords: Campylobacter; Salmonella; analytical software; antimicrobial resistance; computational biology; database; foodborne pathogens; genomics; surveillance.

PubMed Disclaimer

Figures

FIG 1
FIG 1
Data processing and analysis flow. Processing steps and isolate inclusion and exclusion criteria are indicated by arrows, with the number of isolates retained in each phase indicated in the colored boxes. Thirty-eight isolates were excluded if their AST phenotypes in three or more drug classes differed from predictions based on acquired AMR genes.
FIG 2
FIG 2
Qnr loci affect ciprofloxacin (a) and nalidixic acid (b) MICs in S. enterica. Columns on the x axis correspond to observed MIC values; brackets below indicate the susceptible, intermediate, or resistant (SIR) values for those MICs. On the y axis, colored bars indicate the percentage of isolates sharing the same genotype with a given MIC value. Numbers above each column indicate the number of isolates observed with that MIC and genotypes. In the side legend, the number in parentheses is the number of isolates with the corresponding genotype. "No genes" indicates those isolates lacking any predicted fluoroquinolone resistance genes. oqxAB indicates the presence of these fluoroquinolone resistance genes in an isolate. "qnr" indicates the presence of one of the following Qnr family genes: QnrB2, QnrB19, QnrB77, QnrS1, QnrS2, or an unassigned QnrB family allele. "oqxAB, qnr" indicates an OqxAB, QnrB19 genotype. Point mutations for ciprofloxacin (a) are indicated by the gene in which they occurred, followed by the site and changed residues.
FIG 3
FIG 3
Beta-lactamases confer unexpected decreased susceptibility to amoxicillin-clavulanic acid in S. enterica. x and y axes in Fig. 3. Allelic variants within a beta-lactamase family are grouped together under the family name; an isolate can have multiple alleles belonging to the same family. blaPSE family beta-lactamases are either CARB-2 or unassigned CARB alleles. blaCMY family beta-lactamases were either novel blaCMY alleles or the CMY-2 allele. blaHER indicates either the HER-3 allele or a novel HER-family allele. blaTEM indicates either a novel TEM allele or TEM-1. "No genes" indicates those isolates lacking beta-lactamases.
FIG 4
FIG 4
Gentamicin (a) and kanamycin (b) resistance in S. enterica. Format as described for Fig. 2 except aminoglycoside-modifying genes are grouped together by family. "No genes" indicates isolates lacking any predicted gentamicin and kanamycin resistance genes, respectively.
FIG 5
FIG 5
Schematic representation of the AMRFinder algorithm for (a) searching protein sequences and (b) searching nucleotide sequences.

References

    1. The White House. 2015. National action plan for combatting antibiotic-resistant bacteria. The White House, Washington, DC: https://www.cdc.gov/drugresistance/pdf/national_action_plan_for_combatin....
    1. Clinical and Laboratory Standards Institute. 2018. Performance standards for antimicrobial susceptibility testing, 28th ed. CLSI supplement M100 Clinical and Laboratory Standards Institute, Wayne, PA.
    1. Nijhuis RH, van Maarseveen NM, van Hannen EJ, van Zwet AA, Mascini EM. 2014. A rapid and high-throughput screening approach for methicillin-resistant Staphylococcus aureus based on the combination of two different real-time PCR assays. J Clin Microbiol 52:2861–2867. doi:10.1128/JCM.00808-14. - DOI - PMC - PubMed
    1. Becker K, Denis O, Roisin S, Mellmann A, Idelevich EA, Knaack D, van Alen S, Kriegeskorte A, Kock R, Schaumburg F, Peters G, Ballhausen B. 2016. Detection of mecA- and mecC-positive methicillin-resistant Staphylococcus aureus (MRSA) isolates by the new Xpert MRSA Gen 3 PCR assay. J Clin Microbiol 54:180–184. doi:10.1128/JCM.02081-15. - DOI - PMC - PubMed
    1. Sparbier K, Schubert S, Weller U, Boogen C, Kostrzewa M. 2012. Matrix-assisted laser desorption ionization–time of flight mass spectrometry-based functional assay for rapid detection of resistance against beta-lactam antibiotics. J Clin Microbiol 50:927–937. doi:10.1128/JCM.05737-11. - DOI - PMC - PubMed

Publication types

LinkOut - more resources

Cite

AltStyle によって変換されたページ (->オリジナル) /